Longitudinal Assessment of Patient-reported Outcome Measures in Systemic Sclerosis Patients with Gastroesophageal Reflux Disease - Scleroderma Clinical Trials Consortium.

CONCLUSION: The UCLA GIT 2.0 Reflux scale, PROMIS Reflux scale, and QOLRAD are sensitive to change and can be included in future clinical trials. PMID: 30442827 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30442827?dopt=Abstract

Source: J Rheumatol - November 15, 2018 Category: Rheumatology Authors: McMahan ZH, Frech T, Berrocal V, Lim D, Bruni C, Matucci-Cerinic M, Smith V, Melsens K, Proudman S, Zhang J, Mendoza F, Woods M, Khanna D Tags: J Rheumatol Source Type: research